Growth factors and receptors in cancer

A L Harris1

  • 1ICRF, University of Oxford, Institute of Molecular Medicine, John Radcliffe Hospital, Headington, UK.

Insights

Recent advancements reveal growth factor receptor mechanisms crucial for cancer. Targeting tyrosine kinase receptors, implicated in tumor growth, offers new therapeutic strategies using antibodies or peptide ligands.

Area of Science:

  • Oncology and Molecular Biology
  • Cancer Research
  • Signal Transduction

Background:

  • Growth factors and their receptors play critical roles in cellular processes.
  • The tyrosine kinase receptor family is frequently implicated in tumor development and progression.
  • These receptors are often linked to oncogene activation and signaling pathways.

Purpose of the Study:

  • To review recent developments in the mechanisms of action of growth factors and their receptors.
  • To highlight the relevance of these mechanisms, particularly tyrosine kinase receptors, in cancer.
  • To discuss potential therapeutic strategies targeting these pathways.

Main Methods:

  • Literature review of recent developments in growth factor receptor signaling.
  • Analysis of the role of tyrosine kinase receptors in oncogenesis.
  • Exploration of antibody and peptide-based therapeutic approaches.

Main Results:

  • Tyrosine kinase receptors are key mediators of tumor growth.
  • These receptors are products of oncogenes or interact with oncogenic pathways.
  • Antibodies and peptide analogues targeting these receptors show therapeutic potential.

Conclusions:

  • Understanding growth factor receptor mechanisms is vital for cancer therapy.
  • Targeting tyrosine kinase receptors offers promising avenues for cancer treatment.
  • Therapeutic agents like antibodies and peptide ligands can disrupt tumor growth signaling.

Related Concept Videos

Cancer02:18

Cancer

Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...